Hollywood DP - Search Results

1

Expression of the ERBB3 gene product in breast cancer.

Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC. Lemoine NR, et al. Among authors: hollywood dp. Br J Cancer. 1992 Dec;66(6):1116-21. doi: 10.1038/bjc.1992.420. Br J Cancer. 1992. PMID: 1333787 Free PMC article.

2

Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma.

Hollywood DP, Hurst HC. Hollywood DP, et al. Br J Cancer. 1995 Apr;71(4):753-7. doi: 10.1038/bjc.1995.146. Br J Cancer. 1995. PMID: 7710940 Free PMC article.

3

A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.

Hollywood DP, Hurst HC. Hollywood DP, et al. EMBO J. 1993 Jun;12(6):2369-75. doi: 10.1002/j.1460-2075.1993.tb05891.x. EMBO J. 1993. PMID: 8099545 Free PMC article.

4

Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease.

Foley R, Hollywood D, Lawler M. Foley R, et al. Endocr Relat Cancer. 2004 Sep;11(3):477-88. doi: 10.1677/erc.1.00699. Endocr Relat Cancer. 2004. PMID: 15369449 Review.

5

Signal transduction.

Hollywood D. Hollywood D. Br Med Bull. 1991 Jan;47(1):99-115. doi: 10.1093/oxfordjournals.bmb.a072465. Br Med Bull. 1991. PMID: 1713803 Review.

6

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.

Gillham CM, Lucey JA, Keogan M, Duffy GJ, Malik V, Raouf AA, O'byrne K, Hollywood D, Muldoon C, Reynolds JV. Gillham CM, et al. Br J Cancer. 2006 Nov 6;95(9):1174-9. doi: 10.1038/sj.bjc.6603412. Epub 2006 Oct 3. Br J Cancer. 2006. PMID: 17024121 Free PMC article.

7

Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer.

Perry AS, O'Hurley G, Raheem OA, Brennan K, Wong S, O'Grady A, Kennedy AM, Marignol L, Murphy TM, Sullivan L, Barrett C, Loftus B, Thornhill J, Hewitt SM, Lawler M, Kay E, Lynch T, Hollywood D. Perry AS, et al. Int J Cancer. 2013 Apr 15;132(8):1771-80. doi: 10.1002/ijc.27798. Epub 2012 Sep 28. Int J Cancer. 2013. PMID: 22915211 Free PMC article.

8

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.

Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RW, Woodson K, Lawler M. Perry AS, et al. Br J Cancer. 2007 May 21;96(10):1587-94. doi: 10.1038/sj.bjc.6603767. Epub 2007 Apr 24. Br J Cancer. 2007. PMID: 17453001 Free PMC article.

9

IGFBP7 promoter methylation and gene expression analysis in prostate cancer.

Sullivan L, Murphy TM, Barrett C, Loftus B, Thornhill J, Lawler M, Hollywood D, Lynch T, Perry AS. Sullivan L, et al. J Urol. 2012 Oct;188(4):1354-60. doi: 10.1016/j.juro.2012.06.002. Epub 2012 Aug 17. J Urol. 2012. PMID: 22906661

10

The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.

Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, O'Grady A, Kay E, Dunne B, Loftus B, Watson WR, Fitzpatrick JM, Woodson K, Lehman T, Hollywood D, Lynch TH, Lawler M. Foley R, et al. Cancer Biol Ther. 2009 Jan;8(2):118-24. doi: 10.4161/cbt.8.2.7086. Epub 2009 Feb 1. Cancer Biol Ther. 2009. PMID: 19106642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page